Perceptions of HPV vaccination and pharmacist-physician collaboration models to improve HPV vaccination rates.
Perceptions of HPV vaccination and pharmacist-physician collaboration models to improve HPV vaccination rates.
复制标题
对 HPV 疫苗接种和提高 HPV 疫苗接种率的药剂师-医生合作模式的看法。
DOI：
10.1016/j.rcsop.2021.100014
复制
发表时间：
2021
期刊：
影响因子：
--
通讯作者：
Curran,GeoffreyM
中科院分区：
文献类型：
--
作者：
Teeter,BenjaminS;Jensen,CatherineR;Thomas,JeremyL;Martin,BradleyC;McElfish,PearlA;Mosley,CynthiaL;Curran,GeoffreyM
人类乳头瘤病毒（HPV）是美国最常见的性传播疾病，有12种致癌病毒株。美国南部的疫苗接种率低于全国平均水平。药房提供了提高疫苗接种率的机会。本研究的目的是1）确定在药店和诊所提供HPV疫苗和儿童疫苗（VFC）计划参与的障碍和促进因素，2）评估药店工作人员，诊所工作人员和家长对3种合作模式的看法，以改善HPV疫苗接种。方法对药房工作人员、初级保健诊所工作人员和青少年儿童的父母进行发展形成性评价。访谈指南由实施研究综合框架（CFIR）提供。探讨了HPV疫苗接种和VFC参与的障碍和促进因素。此外，还探讨了3种合作模式的可接受性：1）分担责任模式，其中医生提供第一剂HPV疫苗，第二剂由药房提供; 2）基于药房的模式，其中诊所将患者转诊到药房接受两剂疫苗; 3）内包模式，其中药剂师安排天数在合作诊所提供疫苗。结果在2019年8月至2020年6月期间进行了29次访谈。药房和诊所工作人员对HPV疫苗和疫苗接种普遍持积极态度。药剂师和医生报告说，父母的认识和教育是HPV疫苗接种的障碍。据报道，由于与疫苗相关的耻辱感，有关HPV疫苗的咨询更耗时。父母愿意让他们的孩子在药店接种HPV疫苗，但希望他们孩子的医生参与免疫过程。责任分担模式是三种合作模式中最受欢迎的。结论居民对HPV疫苗和药店接种的认知是积极的。诊所和药房之间的合作，以提高HPV疫苗接种率被药房工作人员，诊所工作人员和家长积极看待。这项研究将指导药师-医生合作模式的实施，通过药房参与VFC计划和HPV疫苗接种来改善疫苗接种。
Background Human Papillomavirus (HPV) is the most common sexually transmitted disease in the United States (US), with 12 cancer causing strains. Vaccination rates in the southern US fall below the national average. Pharmacists provide an opportunity to improve vaccination rates. Objectives The objectives of this study were to 1) identify barriers and facilitators to providing the HPV vaccine and Vaccines for Children (VFC) program participation in pharmacies and clinics, and 2) assess pharmacy staff, clinic staff, and parent perceptions of 3 collaboration models to improve HPV vaccination. Methods A developmental formative evaluation was conducted with pharmacy staff, primary care clinic staff, and parents of adolescent children. Interview guides were informed by the Consolidated Framework for Implementation Research (CFIR). Barriers and facilitators to HPV vaccination and VFC participation were explored. Additionally, acceptability of 3 collaboration models were explored: 1) a shared-responsibility model in which a physician provides the first dose of HPV vaccine with the second provided in the pharmacy, 2) a pharmacy-based model in which a clinic refers patients to the pharmacy to receive both doses, and 3) an insourced model in which pharmacists schedule days to provide the vaccine in the collaborating clinic. Results Twenty-nine interviews were conducted between August 2019 and June 2020. Both pharmacy and clinic staff had positive views toward the HPV vaccine and vaccinations in general. Pharmacists and physicians reported parental awareness and education as a barrier to HPV vaccination. Counseling about HPV vaccine was reported as being more time-consuming because of the stigma associated with the vaccine. Parents were willing to have their children vaccinated for HPV in the pharmacy but desired their child's physician be involved in the immunization process. The shared-responsibility model was the most favored of the 3 collaboration models. Conclusion Perceptions of the HPV vaccine and vaccination in pharmacies were positive. Collaboration between clinics and pharmacies to improve HPV vaccination rates is viewed positively by pharmacy staff, clinic staff, and parents. This study will guide implementation of pharmacist-physician collaborative models to improve vaccination through pharmacy participation in the VFC program and HPV vaccination.